Security Reports
CRISPR Therapeutics

CRISPR Therapeutics

This is a preliminary report on CRISPR Therapeutics’s security posture. If you want in-depth, always up-to-date reports on CRISPR Therapeutics and millions of other companies, consider booking a demo with us. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.

UpGuard Security Rating

/ 950
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CRISPR Therapeutics has good security practices.
CRISPR Therapeutics
Basel, BS, Switzerland.
Last updated
Last updated
Last updated today

CRISPR Therapeutics Data Breaches and Security News

Relevant news, breaches and security articles relating to CRISPR Therapeutics.
Last updated today

Security report for CRISPR Therapeutics

Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

More security reports

Compare CRISPR Therapeutics's security performance with other companies.
Deliver icon

Sign up to our newsletter

Get the latest curated cybersecurity news, breaches, events and updates in your inbox every week.
Abstract shapeAbstract shape
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan ratingAbstract shape

Book a free demo

Book a free, personalized onboarding call with one of our cybersecurity experts.
Want a deeper scan?
Get a guided tour of your organization’s security posture from an UpGuard team member.